CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
China Resources Double-Crane Pharmaceutical Company Limited Company Snapshot
China Resources Double-Crane Pharmaceutical Company Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares China Resources Double-Crane Pharmaceutical Company Limited with three other companies in this sector in China: Shandong Xinhua Pharmaceutical Company Limited (2017 sales of 4.52 billion Chinese Renmimbi [US$714.84 million] of which 44% was Preparations), Apeloa Pharmaceutical Co Ltd (5.55 billion Chinese Renmimbi [US$878.84 million] of which 100% was Health Care & Pharmaceutical), and Zhejiang Nhu Co Ltd (6.23 billion Chinese Renmimbi [US$985.65 million] of which 95% was Pharmaceutical Chemicals).

Sales Analysis. During the year ended December of 2017, sales at China Resources Double-Crane Pharmaceutical Company Limited were 6.42 billion Chinese Renmimbi (US$1.02 billion). This is an increase of 16.9% versus 2016, when the company's sales were 5.49 billion Chinese Renmimbi. This was the third consecutive year of growth at China Resources Double-Crane Pharmaceutical Company Limited. The sales level in 2017 was fairly close to the level five years ago: in 2012, China Resources Double-Crane Pharmaceutical Company Limited had sales of 6.99 billion Chinese Renmimbi. Sales of Non- Transfusion saw an increase of 28.6% in 2017, from 3.38 billion Chinese Renmimbi to 4.35 billion Chinese Renmimbi. Not all segments of China Resources Double-Crane Pharmaceutical Company Limited experienced an increase in sales in 2017: sales of Transfusion fell 1.8% to 2.09 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
China Resources Double-Crane Pharmaceutical Company Limited
  Stock Performance Chart for China Resources Double-Crane Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 23.25
(Figures in Chinese Renmimbi)
1 Week 0.6%   13 Weeks -2.4%  
4 Weeks -2.0%   52 Weeks 22.4%  
 
China Resources Double-Crane Pharmaceutical Company Limited Key Data:
  Ticker: 600062 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 6,421,846,769
(Year Ending Jan 2018).
Employees: 12,479
  Currency: Chinese Renmimbi Market Cap: 20,212,730,624
  Fiscal Yr Ends: December Shares Outstanding: 869,364,758
  Share Type: A Gu Closely Held Shares: 553,123,290
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.